As the global population ages, the healthcare system faces unprecedented challenges in managing age-related diseases and maintaining quality of life among older adults. Emerging research suggests that molecular hydrogen (H₂), a simple yet remarkably potent therapeutic agent, may offer significant benefits for senior health and longevity. Unlike many pharmaceutical interventions that target specific pathways, hydrogen gas works through multiple biological mechanisms to address the fundamental processes underlying aging and age-related disease. This review examines the scientific evidence supporting hydrogen inhalation as a promising therapeutic approach for seniors, focusing on its efficacy in preventing cognitive decline, reducing inflammatory conditions, and improving physical function.

Hydrogen inhalation represents a non-invasive, safe, and accessible intervention that has gained increasing attention in geriatric medicine. The safety of H2 gas inhalation was approved by a Phase I clinical trial, establishing its potential as a viable therapeutic option for vulnerable elderly populations. With aging societies increasingly seeking preventive and therapeutic strategies to enhance healthy lifespan, hydrogen therapy offers a compelling science-based approach worthy of clinical consideration.

Mechanisms of Action: Oxidative Stress and Inflammation

The biological mechanisms underlying aging and age-related diseases involve two interconnected processes: oxidative stress and chronic inflammation. Molecular hydrogen has been reported to function as an anti-oxidant and anti-inflammatory agent for treatment of several oxidative stress and aging-related diseases, including Alzheimer's, Parkinson's, cancer and osteoporosis. Understanding how hydrogen exerts these protective effects is essential for appreciating its therapeutic potential.

At the cellular level, aging is characterized by the accumulation of reactive oxygen species (ROS)—harmful free radicals that damage proteins, lipids, and DNA. Hydrogen is one of the smallest elements, allowing it to easily penetrate cell membranes and enter cells, where it acts as a potent antioxidant, neutralizing harmful free radicals. Notably, H₂ selectively neutralizes free radicals, such as hydroxyl (•OH) and peroxynitrite (ONOO⁻), offering a selective mechanism that differs from broad-spectrum antioxidants.

The anti-inflammatory effects of hydrogen operate through several pathways. Hydrogen may prevent inflammation and regulate the nutrient-sensing mTOR system, autophagy, apoptosis, and mitochondria, which are all factors related to aging. This multipronged approach makes hydrogen uniquely suited for addressing the complex biology of aging. Additionally, H2 downregulates the expression of pro-inflammatory cytokines like IL-1β, IL-6, TNF-α, and ICAM-1, responsible for inflammation, pain, and swelling, and also inhibits the activation of inflammatory signaling pathways like NF-κB and MAPK.

Prevention of Postoperative Delirium and Cognitive Dysfunction

Postoperative delirium represents a significant clinical challenge in geriatric medicine, affecting quality of life and recovery outcomes in elderly surgical patients. A landmark randomized controlled trial demonstrated the efficacy of hydrogen inhalation in this population. In a study of 184 patients aged ≥65 years, postoperative delirium occurred in 17 (24%) of 70 patients without hydrogen inhalation and in 10 (12%) of 83 patients after hydrogen inhalation, with the incidence of delirium decreased in the hydrogen group. Furthermore, the postoperative C-reactive protein level was significantly lower in the hydrogen group than the control group, suggesting that hydrogen's protective mechanism operates through inflammation reduction.

Beyond acute surgical settings, hydrogen inhalation shows promise for chronic cognitive decline. For dementia, a subgroup analysis of a randomized clinical trial reported that H2 improved conditions of subjects with mild cognitive impairment (MCI) who carry the apolipoprotein E4 (APOE4) genotype. This finding is particularly significant because the APOE4 genotype is associated with increased Alzheimer's disease risk, suggesting hydrogen may benefit those at highest genetic risk for cognitive decline.

A prospective clinical trial examining hydrogen's effects on Alzheimer's disease biomarkers revealed encouraging results. Evaluation of dementia-related biomarkers, such as beta-site APP cleaving enzyme 1 (BACE-1), amyloid beta (Aβ), brain-derived neurotrophic factor (BDNF), vascular endothelial growth factor A (VEGF-A), T-tau, monocyte chemotactic protein-1 (MCP-1), and inflammatory cytokines showed that their cognitive condition significantly improved after treatment in most cases. These findings suggest that hydrogen may slow or halt the neuropathological processes underlying Alzheimer's disease.

Anti-Aging Effects and Cellular Longevity

The aging process is fundamentally characterized by progressive loss of cellular function and telomere shortening. Recent evidence suggests that hydrogen may directly impact these aging hallmarks. A study examining a six-month intervention involving hydrogen-rich water in elderly patients over the age of 70 found that hydrogen-rich water led to an approximate 4% increase in mean telomere length, exhibited a tendency to enhance DNA methylation, and demonstrated a substantial improvement in chair-stand capacity. These findings suggest hydrogen may operate as a genuine anti-aging intervention, not merely symptomatic relief.

The improvement in physical performance markers is particularly noteworthy for seniors concerned with maintaining independence and preventing frailty. Hydrogen inhalation therapy has shown potential in treating ischemia-reperfusion injury, myocardial infarction, and organ transplantation, with recent studies suggesting that hydrogen gas, when inhaled, may reduce proinflammatory cytokines and pro-apoptotic factors.

Management of Osteoarthritis and Joint Pain

Joint pain and osteoarthritis represent major sources of disability and reduced quality of life in elderly populations. A randomized controlled trial specifically examined hydrogen's effects on knee osteoarthritis in seniors. In a randomized controlled trial of elderly knee osteoarthritis patients randomly assigned to either a hydrogen-oxygen mixture inhalation group or control group, both participating in a 12-week home-based exercise program, H₂-O₂ inhalation alleviated knee osteoarthritis symptoms and enhanced functional activity in elderly patients during the initial 2 weeks.

Although the study noted that sustained effects beyond the initial treatment period were not observed, these findings demonstrate hydrogen's capacity to provide meaningful short-term symptomatic relief, potentially facilitating greater participation in physical rehabilitation—crucial for maintaining mobility and preventing disability in older adults.

Gastrointestinal Health and Gut Microbiome

Emerging research highlights the importance of gastrointestinal health in overall aging and longevity. Hydrogen inhalation therapy offers benefits for gut health and supports healthy microbiome function, contributing to improved digestion, nutrient absorption, and immune function—processes that commonly decline with age. A healthy gut microbiome is increasingly recognized as fundamental to systemic health, influencing metabolism, immune responses, cognitive function, and inflammation regulation. By supporting gastrointestinal health through antioxidant and anti-inflammatory mechanisms, hydrogen inhalation may provide broader benefits for overall geriatric health beyond its direct organ-system effects.

The gut-brain axis and gut-immune interactions are particularly relevant for seniors managing multiple age-related conditions. Maintaining optimal gastrointestinal function through hydrogen therapy may represent an underappreciated avenue for comprehensive health optimization in aging populations.

Cardiovascular and Metabolic Disease Management

Aging is accompanied by increased cardiovascular and respiratory disease risk, representing the leading causes of morbidity and mortality in seniors. In the context of pulmonary disease, inhaling hydrogen gas has been found beneficial for protecting lung tissue from chronic oxidative and inflammatory stress, particularly important given the rising incidence of pulmonary disease in aging populations exposed to multiple environmental factors.

For cardiovascular health, the anti-inflammatory and anti-oxidant properties of hydrogen are particularly relevant. H₂ selectively quenches toxic ROS and has an anti-apoptotic, anti-oxidant, anti-inflammatory and anti-allergic impact, with studies examining its effects in heart failure due to radiation, ischemia-reperfusion (I/R), myocardial infarction, brain infarction, and heart transplants. These diverse applications suggest hydrogen's broad utility in managing the cardiovascular complications common in aging.

Beyond cardiac health, hydrogen inhalation therapy shows promise in managing diabetes and related metabolic disorders, conditions that significantly increase morbidity and mortality risk in elderly populations. The metabolic benefits of hydrogen inhalation complement its anti-inflammatory and antioxidant mechanisms, addressing multiple pathways involved in diabetic complications and age-related metabolic dysfunction.

Safety Profile and Tolerability

A critical consideration for any geriatric intervention is safety, particularly for vulnerable older adults who often take multiple medications and have comorbid conditions. The safety evidence supporting hydrogen inhalation is reassuring. No adverse effects were recorded after four weeks of treatment with H2 gas inhalation, with the total and differential white blood cell counts not adversely affected after H2 gas inhalation, indicating that it was safe and well tolerated.

This safety profile extends to extended use. In a pilot study, no adverse events were seen during hydrogen inhalation therapy, even in populations with complex neurological conditions. The lack of reported adverse effects across multiple clinical trials demonstrates that hydrogen inhalation can be safely incorporated into comprehensive geriatric care protocols without concerns about toxicity or iatrogenic harm.

Clinical Implementation and Practical Considerations

The delivery method for hydrogen therapy has evolved with advances in technology. Hydrogen is now available as a medical gas for clinical patients, with recent development of a hydrogen-oxygen nebulizer that combines the advantages of conventional electrolysis and ion membrane technology by adding AC/DC conversion to pure water electrolysis, outputting a gas mixture of 66.6% hydrogen and 33.3% oxygen at different flow rates for clinical selection. This hydrogen-oxygen mixture (H₂-O₂) represents an optimized formulation for therapeutic inhalation, balancing hydrogen's therapeutic benefits with oxygen's essential physiological role.

For seniors, the practical advantages of hydrogen inhalation are significant. Unlike pharmaceutical interventions requiring daily medication management, hydrogen therapy can be administered in brief, scheduled sessions using standardized equipment. The non-invasive nature of inhalation, combined with minimal adverse effects, makes it particularly suitable for older adults with swallowing difficulties, complex medication regimens, or concerns about drug interactions.

Implementation in clinical settings should consider individual patient circumstances. H₂ crosses the thin alveolar membrane in the lungs and reaches arterial blood within seconds, with arterial concentrations tracking inspired hydrogen percentage almost linearly. This rapid delivery to systemic circulation suggests that even brief inhalation sessions may produce meaningful physiological effects.

Limitations and Future Directions

While the evidence supporting hydrogen inhalation is encouraging, several limitations warrant acknowledgment. Most clinical trials have involved relatively small participant numbers and limited duration of follow-up. Additionally, optimal dosing protocols, frequency of administration, and patient selection criteria remain areas requiring further research. The heterogeneity of conditions studied makes it challenging to develop unified treatment recommendations applicable across all geriatric populations.

Future research should prioritize large, multicenter randomized controlled trials examining hydrogen inhalation in common senior health challenges, including cognitive decline, cardiovascular disease, and mobility limitations. Mechanistic studies using advanced neuroimaging and biomarker analysis may further elucidate how hydrogen produces its therapeutic effects, potentially identifying populations most likely to benefit.

Conclusion

Molecular hydrogen represents a promising therapeutic agent for addressing the complex, multifactorial processes underlying aging and age-related disease. With its dual antioxidant and anti-inflammatory properties, hydrogen inhalation addresses fundamental pathobiological mechanisms rather than targeting isolated symptoms. The growing body of clinical evidence demonstrates efficacy in preventing postoperative delirium, improving cognitive function, reducing inflammatory markers, and maintaining physical performance in older adults.

The safety profile of hydrogen inhalation, demonstrated across multiple clinical trials, makes it a potentially attractive addition to comprehensive geriatric care programs. As healthcare systems increasingly seek preventive strategies that enhance healthy aging while reducing disease burden, hydrogen therapy merits serious clinical consideration. For seniors seeking to optimize health outcomes and maintain independence, hydrogen inhalation offers a non-invasive, evidence-based approach grounded in rigorous scientific investigation.

Future integration of hydrogen therapy into geriatric medicine may contribute meaningfully to extending not merely lifespan, but healthy lifespan—enabling older adults to maintain cognitive vitality, physical function, and quality of life throughout their years.

References

1. Rahman, M. H., Bajgai, J., Sharma, S., et al. (2023). Effects of Hydrogen Gas Inhalation on Community-Dwelling Adults of Various Ages: A Single-Arm, Open-Label, Prospective Clinical Trial. Antioxidants, 12(6), 1241. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10295751/
2. Xie, K., Liu, Y., Li, S., et al. (2022). Hydrogen Gas Treatment Improves Postoperative Delirium and Cognitive Dysfunction in Elderly Noncardiac Patients. Frontiers in Aging Neuroscience, 14, 803813. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9867387/
3. Lin, X., Cui, M., Chen, W., et al. (2024). Hydrogen-oxygen mixture inhalation as an adjunctive treatment to home-based exercise in older patients with knee osteoarthritis: an open-label, blinded-endpoint, randomized controlled trial. BMC Geriatrics, 24, 123. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11821916/
4. Wang, Q., Song, J., Miao, X., et al. (2024). The Improvement of Physical Function and Caregiver Burden by a Multimodal Intervention: A Case Study of Combined Exercise Therapy, Nutritional Guidance, and Hydrogen Gas Inhalation Therapy. Nutrients, 13(2), 456. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11947501/
5. Ichikawa, H., Nishida, Y., Sato, B., et al. (2021). Role of Molecular Hydrogen in Ageing and Ageing-Related Diseases. International Journal of Molecular Sciences, 22(18), 9818. https://pmc.ncbi.nlm.nih.gov/articles/PMC8956398/
6. Yoshida, Y., Kunitake, T., Yasui, H., et al. (2019). The Anti-Inflammatory Effect of Hydrogen Gas Inhalation and Its Influence on Laser-Induced Choroidal Neovascularization in a Mouse Model of Neovascular Age-Related Macular Degeneration. International Journal of Molecular Sciences, 22(12), 12049. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8584469/
7. Manni, G., Zaccaria, F., Axerio-Cilies, J., et al. (2023). Redox-Mechanisms of Molecular Hydrogen Promote Healthful Longevity. Antioxidants, 12(5), 988. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10215238/
8. Fujita, K., Seike, T., Yutsudo, N., et al. (2021). Randomized double-blind placebo-controlled trial of hydrogen inhalation for Parkinson's disease: a pilot study. Movement Disorders, 36(8), 1931-1940. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8519836/
9. Ohsawa, I., Ishikawa, M., Takahashi, K., et al. (2007). Hydrogen acts as a free radical scavenger and protects against oxidative damage. Nature Medicine, 13(6), 688-694. https://www.ncbi.nlm.nih.gov/pubmed/17486089
10. Ohta, S. (2011). Molecular hydrogen as a preventive and therapeutic medical gas: initiation, development and potential of hydrogen medicine. Pharmacology & Therapeutics, 144(1), 1-11. https://www.ncbi.nlm.nih.gov/pubmed/21295072
11. PEMF Devices. Hydrogen Inhalation Therapy for Diabetes: Clinical Applications in Metabolic Health. https://pemf-devices.com/hydrogen-inhalation-therapy-for-diabetes/
12. PEMF Devices. Comparing Hydrogen Inhalation with Hydrogen-Rich Water for Gut Health and Microbiome Support. https://pemf-devices.com/compare-hydrogen-inhalation-hrw-gut-health/
13. PEMF Devices. Hydrogen-Oxygen Therapy (H₂-O₂): Optimized Formulation for Therapeutic Inhalation. https://pemf-devices.com/hydrogen-oxygen-therapy-h2-o2/